CompaniesAerami Therapeutics

Aerami Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

83

By Phase

PHASE1: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2020

2021

2022

2023

Today

Hover over trial bars to see details

Recent Trials

NCT04903730Lead Sponsor

Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

PHASE1Completed

83 participants

Started: May 24, 2021 · Completed: Dec 2, 2022

Funding History (10)

D

Nov 22, 2023

D

Dec 16, 2022

D/A

Nov 4, 2021

D

Sep 23, 2021

D

Jun 17, 2020

D/A

Jun 11, 2019

D

Jun 10, 2019

D/A

Jan 11, 2018

D

Dec 18, 2017

D/A

Jun 26, 2017